Can the administration of antithrombin III decrease the risk of cerebral hemorrhage in premature infants?

Biology of the Neonate

Volumn 83, Issue 1, 2003, Pages 1-5

  Fulia, Francesco ^a   Cordaro, S ^b   Meo, P ^b   Gitto, P ^b   Gitto, E ^b   Trimarchi, G ^b   Adelardi, S ^b   Barberi, I ^b  

^a 'Barone Romeo' Hospital   (Italy)

^b NONE

Author keywords

Antithrombin III; Cerebral hemorrhage; Premature infants; Thrombophilia

Indexed keywords

ANTITHROMBIN III; PLACEBO;

ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE; DRUG EFFECT; FEMALE; HUMAN; INFANT; LOADING TEST; MALE; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT;

ANTITHROMBIN III; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROTHROMBIN TIME; SERINE PROTEINASE INHIBITORS; THROMBOPHILIA; TREATMENT FAILURE;

EID: 0037234499     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067005     Document Type: Article

References (37)

1. McDonald MM, Johnson ML, Rumack CM, Koops BL, Guggenheim MA, Bobb C, Hathaway WE: Role of coagulopathy in newborn intracranial hemorrhage. Pediatrics 1984;74:26-31.
2. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P: Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-1657.
3. Andrew M, Paes B, Johnston M: Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104.
4. Junker R, Koch HG, Auberger K, Munchow N, Ehrenforth S, Nowak-Gottl U: Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999;19:2568-2572.
5. Petaja J, Hiltunen L, Fellman V: Increased risk of intraventricular hemorrhage in preterm infants with thrombophilia. Pediatr Res 2001;49:643-646.
6. Manco-Johnson MJ: Disorders of hemostasis in childhood: Risk factors for venous thromboembolism. Thromb Haemost 1997;78:710-714.
7. Schmidt B, Vegh P, Weitz J, Johnston M, Caco C, Roberts R: Thrombin/antithrombin III complex formation in the neonatal respiratory distress syndrome. Am Rev Respir Dis 1992;145:767-770.
8. Baudo F, Caimi TM, de Cataldo F, Ravizza A, Arlati S, Casella G, Carugo D, Palareti G, Legnani C, Ridolfi L, Rossi R, D'Angelo A, Crippa L, Giudici D, Gallioli G, Wolfler A, Calori G: Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: A controlled double-blind, randomized, multicenter study. Intensive Care Med 1998;24:336-342.
9. Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B: Thrombophilia as a multigenic disease. Haematologica 1999;84:59-70.
10. Chen JP, Lorch V: Intraventricular haemorrhage in preterm infants: Evidence of suppressed fibrinolysis. Blood Coagul Fibrinolysis 1996;7:289-294.
11. Fujii Y, Takeuchi S, Harada A, Abe H, Sasaki O, Tanaka R: Hemostatic activation in spontaneous intracerebral hemorrhage. Stroke 2001;32:883-890.
12. Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evaluation of subependymal ord intraventricular hemorrhage. A study of infants with birth weight less than 1,500 grams. J Pediatr 1978;92:529-534.
13. Chang GY, Lueder FL, DiMichele DM, Radkowski MA, McWilliams LJ, Jansen RD: Heparin and the risk of intraventricular hemorrhage in premature infants. J Pediatr 1997;131:362-366.
14. Antoniuk S, da Silva RV: Periventricular and intraventricular hemorrhage in the premature infants. Rev Neurol 2000;31:238-243.
15. Dehara M, Morimoto K, Takemoto O, Hirano S, Yoshimine T: Germinal matrix hemorrhage and hydrocephalus in premature infants. No To Shinkei 1999;51:627-631.
16. Paneth N, Pinto-Martin J, Gardiner J, Wallenstein S, Katsikiotis V, Hegyi T, Hiatt IM, Susser M: Incidence and timing of germinal matrix/intraventricular hemorrhage in low birthweight infants. Am J Epidemiol 1993;137:1167-1176.
17. Smith LM, Qureshi N, Chao CR: Effects of single and multiple courses of antenatal glucocorticoids in pretermnewborns less than 30 weeks' gestation. J Matern Fetal Med 2000;9:131-135.
18. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Duncan CC, Makuch RW: Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol 1995;172:795-800.
19. Philip AG, Allan WC: Does cesarean section protect against intraventricular hemorrhage in preterm infants? J Perinatol 1991;11:3-9.
20. Lou HC, Skov H, Pedersen H: Low cerebral blood flow: a risk factor in the neonate. J Pediatr 1979;95:606-609.
21. Jorch G, Jorch N: Failure of autoregulation of cerebral blood flow in neonates studied by pulsed Doppler ultrasound of the internal carotid artery. Eur J Pediatr 1987;146:468-472.
22. Chen JP, Lorch V: Intraventricular haemorrhage in preterm infants: Evidence of suppressed fibrinolysis. Blood Coagul Fibrinolysis 1996;7:289-294.
23. Beverley DW, Chance GW, Inwood MJ, Schaus M, O'Keefe B: Intraventricular haemorrhage and haemostasis defects. Arch Dis Child 1984;59:444-448.
24. Mercuri E, Cowan F, Gupte G, Manning R, Laffan M, Rutherford M, Edwards AD, Dubowitz L, Roberts I: Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics 2001;107:1400-1404.
25. Klinger G, Koren G: Antenatal phenobarbital for prevention of intraventricular hemorrhage in preterm infants. Can Fam Physician 2000;46:1285-1287.
26. Whitelaw A: Postnatal phenobarbitone for the prevention of intraventricular hemorrhage in preterm infants. Cochrane Database Syst Rev 2000;2:CD001691.
27. Rubino CM, Shaffer CL, Gal P, Ransom JL, Kissling GE: Postnatal pharmacologic prevention of intraventricular hemorrhage: Meta-analysis of phenobarbital and indomethacin. Pediatr Nurs 1997;23:196-204.
28. De Lia JE, Billman D: Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: A randomized, double-blind, placebo-controlled trial. Obstet Gynecol 1994;83:1067-1069.
29. Chen JY: Ethamsylate in the prevention of periventricular-intraventricular hemorrhage in premature infants. J Formos Med Assoc 1993;92:889-893.
30. Chiswick M, Gladman G, Sinha S, Toner N, Davies J: Vitamin E supplementation and periventricular hemorrhage in the newborn. Am J Clin Nutr 1991;53:370-372.
31. Sinha S, Davies J, Toner N, Bogle S, Chiswick M: Vitamin E supplementation reduces frequency of periventricular haemorrhage in very preterm babies. Lancet 1987;1:466-471.
32. Kurachi K, Fujikawa K, Schmer G, Davie EW: Inhibition of bovine factors IXa and Xa by antithrombin III. Biochemistry 1976;15:373-377.
33. Peters M, Ten Cate JW, Jansen E, Bruderveld C: Coagulation and fibrinolytic factors in the first week of live in healthy infants. J Pediatr 1985;106:292-295.
34. Okajima K, Uchiba M: The anti-inflammatory properties of antithrombin III: New therapeutic implications. Semin Thromb Hemost 1998;24:27-32.
35. Baudo F, de Cataldo F: Antithrombin III concentrates in the treatment of sepsis and septic shock: Indications, limits and future prospects (in Italian). Minerva Anestesiol 2000;66:3-23.
36. Brangenberg R, Bodensohn M, Bürger U: Antithrombin-III substitution in preterm infants: Effect on intracranial hemorrhage and coagulation parameters. Biol Neonate 1997;72:76-83.
37. Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R: A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:470-476.